Transcatheter aortic valve replacement (TAVR) has developed substantially since its inception. Improvements in valve design, valve deployment technologies, preprocedural imaging and increased operator experience have led to a gradual decline in length of hospitalisation after TAVR. Despite these advances, the need for permanent pacemaker implantation for post-TAVR high-degree atrioventricular block (HAVB) has persisted and has well-established risk factors which can be used to identify patients who are at high risk and advise them accordingly. While most HAVB occurs within 48 hours of the procedure, there is a growing number of patients developing HAVB after initial hospitalisation for TAVR due to the trend for early discharge from hospital. Several observation and management strategies have been proposed. This article reviews major known risk factors for HAVB after TAVR, discusses trends in the timing of HAVB after TAVR and reviews some management strategies for observing transient HAVB after TAVR.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353545 | PMC |
| http://dx.doi.org/10.15420/cfr.2021.05 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Management of Postprocedural Conduction Disturbances Using a Prespecified Algorithm in the Optimize PRO Study.
J Soc Cardiovasc Angiogr Interv
January 2024
Quebec Heart & Lung Institute, Laval University, Quebec City, Quebec, Canada.
Article Synopsis
- * Optimize PRO, a prospective study, implements two strategies: using a cusp overlap technique during TAVR and a CD algorithm that assesses patients based on their post-procedure ECG for early discharge decisions.
- * Results indicate that patients with conduction disturbances had a significantly higher PPI rate at 30 days compared to those without (28.1% vs 1.5%), but the standardized management of CDs led to similar safety outcomes, suggesting effective early recognition and monitoring of arrhythm
Thirty-Day High-Grade Aortic Valve Block Post-Transcatheter Aortic Valve Replacement in Patients Discharged on Heart Rhythm Monitor.
Struct Heart
July 2024
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Background: Conduction disease is an important and common complication post-transcatheter aortic valve replacement (TAVR). Previously, we developed a conduction disease risk stratification and management protocol post-TAVR. This study aims to evaluate high-grade aortic valve block (HAVB) incidence and risk factors in a large cohort undergoing ambulatory cardiac monitoring post-TAVR according to conduction risk grouping.
View Article and Find Full Text PDFSmartwatch-Detected Arrhythmias in Patients After Transcatheter Aortic Valve Replacement (TAVR): Analysis of the SMART TAVR Trial.
J Med Internet Res
July 2024
department of Cardiology, Zhejiang University, Hangzhou, China.
Article Synopsis
- The study investigates the development of arrhythmias in patients at risk of high-degree atrioventricular block (HAVB) or complete heart block (CHB) after undergoing transcatheter aortic valve replacement (TAVR) using smartwatch technology.
- It analyzes data from 188 patients monitored for 30 days post-TAVR, focusing on the incidence and timing of arrhythmic events and pacemaker implantation.
- Results show an increased incidence of left bundle branch block (LBBB) initially, with higher pacemaker implantation rates in patients at greater risk of HAVB/CHB, and identified factors predictive of needing a pacemaker.
Permanent pacemaker reduction using temporary-permanent pacemaker as a 1-month bridge after transcatheter aortic valve replacement: a prospective, multicentre, single-arm, observational study.
EClinicalMedicine
June 2024
Interventional Center of Valvular Heart Disease, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing, China.
Background: The permanent pacemaker (PPM) implantation and pacemaker dependency rates after transcatheter aortic valve replacement (TAVR) are highly variable as some of the conduction disturbances are reversible. It remains poorly investigated how to optimise temporary pacing in these patients. This study aimed to explore the potential reduction in the PPM implantation rate using temporary-permanent pacemaker (TPPM) as a 1-month bridge.
View Article and Find Full Text PDFPredictors, clinical impact, and management strategies for conduction abnormalities after transcatheter aortic valve replacement: an updated review.
Front Cardiovasc Med
April 2024
Department of Cardiology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Transcatheter aortic valve replacement (TAVR) has increasingly become a safe, feasible, and widely accepted alternative surgical treatment for patients with severe symptomatic aortic stenosis. However, the incidence of conduction abnormalities associated with TAVR, including left bundle branch block (LBBB) and high-degree atrioventricular block (HAVB), remains high and is often correlated with risk factors such as the severity of valvular calcification, preexisting conditions in patients, and procedural factors. The existing research results on the impact of post-TAVR conduction abnormalities and permanent pacemaker (PPM) requirements on prognosis, including all-cause mortality and rehospitalization, remain contradictory, with varied management strategies for post-TAVR conduction system diseases across different institutions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!